Medicare Recipients Face Big Premium Hike

Source: Common Dreams

“Medicare Part B recipients will soon be hit with one of the biggest premium increases in the history of the government program, a hike driven in large part by the Food and Drug Administration’s scandalous approval of a costly (and, according to many experts, dubious) Alzheimer’s drug. Last week, the Centers for Medicare and Medicaid Services (CMS) announced that monthly Medicare Part B premiums will be raised to $170.10 in 2022, up from this year’s level of $148.50. While CMS officials cited several factors in their explanation of the premium boost — including costs imposed by the coronavirus pandemic — they attributed roughly half of the increase to ‘additional contingency reserves due to the uncertainty regarding the potential use of the Alzheimer’s drug, Aduhelm, by people with Medicare.’ Medicare is currently in the process of deciding whether to cover the drug, which is priced at a staggering $56,000 per year.” (11/16/21)

https://www.commondreams.org/news/2021/11/16/reckless-fda-and-big-pharma-greed-blamed-medicare-premium-hike